PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3619693

[A method of processing small biopsy specimens embedded in paraffin using xylene].

V Ia Suponitskiĭ
View original source ↗Export metadata ↓

Abstract

The method proposed for the processing of gastrobiopsies is as follows: 30-40 min in solution I (seventy per cent 96% ethyl alcohol and 30% of turpentine), then 30-40 min in solution II (100 parts of turpentine, 5 parts of balzam and 8 parts of castor oil), 4 portions of melted paraffin for 7.5-10 min in each portion. Small biopsies (up to 5 mm in diameter) are treated in the same way but till 3 hrs in solution I, 6-8 hrs in solution II and 30 min in each portion of paraffin. For an instant processing of biopsies of operation and autopsy material the basic solution is prepared: 1000 ml of xylene, 100-120 g of balzam, 150 ml of ol. ricini. The material is treated in two portions of ethyl alcohol (30-150 min in each portion); two portions of mixture A; 80% of acetone and 20% of the basic solution), 3 hrs in each portion; two portions of mixture B (20% of acetone and 80% of basic solution), 2 hrs in each portion; and in 6 portions of melted paraffin, 30 min in each portion. The technique provides good results for the processing of small biopsies from other organs.

Explore related subjects

BiopsyFixativesHumansParaffinSpecimen HandlingXylenesEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V Ia Suponitskiĭ. 1987. [A method of processing small biopsy specimens embedded in paraffin using xylene].. https://pubmed.ncbi.nlm.nih.gov/3619693/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗